Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Philippe Moreau(Institut Paoli-Calmettes), Jean‐Luc Harousseau, Rafaël Fonseca(Mayo Clinic in Arizona), P. Leif Bergsagel(Mayo Clinic in Arizona), Enrique M. Ocio(Universidad de Salamanca), Dominik Dytfeld, Hermann Einsele(University of Würzburg), Surbhi Sidana(Centro de Investigación del Cáncer), Christoph Driessen(Kantonsspital St. Gallen), Jesús F. San Miguel(Universidad de Salamanca), Cristina João(Universidade Nova de Lisboa), Katja Weisel(Universität Hamburg), Sagar Lonial(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Ângelo Maiolino(Universidade Federal do Rio de Janeiro), Thierry Façon(Inserm), Brian G.M. Durie(Spanish Head & Neck Cancer Cooperative Group), Shaji Kumar(Mayo Clinic in Arizona), Heinz Ludwig(Wilhelminen Hospital), Suzanne Lentzsch(UPMC Hillman Cancer Center), Joan Bladé(Spanish Head & Neck Cancer Cooperative Group), Kenneth C. Anderson(Novartis (Switzerland)), Niels W.C.J. van de Donk(Amsterdam UMC Location Vrije Universiteit Amsterdam), Faith E. Davies(Institute of Cancer Research), Evangelos Terpos(National and Kapodistrian University of Athens), Ulf‐Henrik Mellqvist, Artur Jurczyszyn(Jagiellonian University), Xavier Leleu(Harvard University), Jesús G. Berdeja(Université Paris Cité), Anders Waage(St Olav's University Hospital), Noopur Raje(Dana-Farber Cancer Institute), Elena Zamagni(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Joseph Mıkhael(Translational Genomics Research Institute), Thomas G. Martin(University of California San Francisco Medical Center), Monika Engelhardt(University of Freiburg), Nizar J. Bahlis(University of Calgary), Wee Joo Chng(National University Health System), Kwee Yong(London Cancer), Annette Juul Vangsted(Copenhagen University Hospital), Michèle Cavo(University of Bologna), Rachid Baz(Moffitt Cancer Center), Fredrik Schjesvold(Oslo University Hospital), Eloísa Riva(Hospital de Clínicas), Roman Hájek(University Hospital Brno), Hang Quach(The University of Melbourne), Vânia Hungria(São Germano Oncologia), Fernando Leal da Costa(University of Alabama at Birmingham), Jian Hou, Sigurður Y. Kristinsson(University of Iceland), David H. Vesole(Saint Vincent Health System), Pieter Sonneveld(Erasmus MC Cancer Institute)
Cited by 266
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k